2367.HK
Giant Biogene is China’s largest collagen skin care products maker and has grown rapidly from 957 million yuan in revenue in 2019 to 3.52 billion yuan last year.

The Latest: Chinese skin-care products maker Giant Biogene Holding Co. Ltd. (2367.HK) reported Monday its net profit jumped 47.3% to 983 million yuan ($138 million) in the first half of this year.

Looking Up: The company’s revenue surged 58.2% to 2.54 billion yuan on its continued addition of new products, expansion of sales channels, creation of star products and stronger marketing.

Take Note: The company’s selling and distribution expenses jumped 60.7% to 892 million yuan, outpacing revenue growth, as it spent heavily on online marketing to promote its online direct sales channels

Digging Deeper: Giant Biogene is China’s largest collagen skin care products maker and has grown rapidly from 957 million yuan in revenue in 2019 to 3.52 billion yuan last year. The company’s gross margin has exceeded 83% for the past five years, reflecting the high profitability of its business. It made its Hong Kong trading debut in late 2022, becoming the first listed company in its category. In May, the company raised a fresh HK$1.63 billion ($208 million) through a share placement to strengthen its core business and ecosystem layout.

Market Reaction: Giant Biogene shares fluctuated slightly on Tuesday, closing up down 0.2% at HK$40.25 by the midday break. The stock now trades in the middle of its 52-week range.

Translation by A. Au

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Qudian abandons last mile delivery

Qudian: A slow-motion privatization?

The company said it is contemplating winding down its last-mile delivery service after stiff competition caused its revenue to plunge in the first quarter Key Takeaways: Qudian’s revenue fell by…
Yeahka secures bridgehead in U.S. payments market

Yeahka secures bridgehead in U.S. payments market

The Chinese fintech has cleared one of many regulatory hurdles to enter the U.S. digital payments business after gaining a state-level operating license Key Takeaways: After getting U.S. federal clearance,…
Sante makes infant nutritional products

Sainte Nutritional nurtures Hong Kong IPO

The Qingdao-based maker of food for special medical purposes is challenging international firms that still dominate the China market but could face tariff uncertainties Key Takeaways: Sainte Nutritional has filed…